Economics ❯Market Trends ❯Stock Performance ❯Sector Analysis
President Trump’s executive order to reduce US drug prices by up to 80% and adopt a Most Favoured Nation policy triggers sell-off in Indian pharmaceutical shares despite broader market gains.
